Stimcell Energetics (STME) Cash from Financing Activities (2011 - 2026)

Stimcell Energetics' (STME) quarterly Cash from Financing Activities came in at $50000.0 in Q1 2026, up 198.6% year-on-year from $16745.0 in Q1 2025, and down 56.24% quarter-over-quarter from $114248.0 in Q4 2025.

Stimcell Energetics (STME) Cash from Financing Activities (2011 - 2026) Analysis & Trends

Stimcell Energetics' Cash from Financing Activities history runs 13 years deep, the most recent figure standing at $50000.0 for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 198.6% year-over-year to $50000.0 in Q1 2026; TTM through Feb 2026 was $330361.0, a 672.27% increase from a year earlier, with the FY2025 full-year figure at $112858.0, up 23.97% from the prior year.
  • Cash from Financing Activities eased to $50000.0 in Q1 2026 per STME's latest filing, from $114248.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $116377.0 in Q2 2023 and bottomed at -$3967.0 in Q2 2024.
  • The 5-year median for Cash from Financing Activities is $78686.0 (2022), against an average of $70257.1.
  • Across the five-year window, Cash from Financing Activities tumbled 103.41% in 2024 and surged 1766.57% in 2025, its largest moves.
  • Year by year, Cash from Financing Activities stood at $76372.0 in 2022, then jumped by 52.38% to $116377.0 in 2023, then tumbled by 74.22% to $30000.0 in 2024, then surged by 280.83% to $114248.0 in 2025, then plunged by 56.24% to $50000.0 in 2026.
  • Per Business Quant, the three latest STME Cash from Financing Activities figures stand at $50000.0 (Q1 2026), $114248.0 (Q4 2025), and $100000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Stimcell Energetics 5.85 Mn 5.84 Mn - 50,000.00

Historic Data

Download Data
DateValue
Feb 28, 2026 50,000.00
Feb 28, 2026 50,000.00
Nov 30, 2025 114,248.00
Nov 30, 2025 114,248.00
Aug 31, 2025 100,000.00
Aug 31, 2025 100,000.00
May 31, 2025 66,113.00
May 31, 2025 66,113.00
Feb 28, 2025 16,745.00
Feb 28, 2025 16,745.00
Nov 30, 2024 30,000.00
Nov 30, 2024 30,000.00
May 31, 2024 -3,967.00
May 31, 2024 -3,967.00
Feb 29, 2024 95,000.00
Feb 29, 2024 95,000.00
May 31, 2023 116,377.00
May 31, 2023 116,377.00
Feb 28, 2023 92,615.00
Feb 28, 2023 92,615.00